EUNETWORKS
7.12.2023 09:01:28 CET | Business Wire | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, was recently featured in an interview series with leaders from across industries undertaken during the United Nations Climate Conference (COP28) in Dubai. The series of interviews captures lessons learned, sustainability success stories and key messages for the future from leaders across the energy, technology and telecom, manufacturing and finance industries. euNetworks has also released its latest Sustainability Report, detailing the company’s commitment to sustainability and substantial progress over the last year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231207410743/en/
Paula Cogan, CEO of euNetworks (Photo: Business Wire)
euNetworks builds and invests in city and long haul fibre networks to connect key European data centres and data hubs. The company owns and operates deep fibre networks in 17 cities and also operates a highly differentiated long haul network that spans 66,000 kilometres across 17 countries today. As a specialist in the sector, euNetworks continues to grow and invest in partnership with its customers, investing in new technologies and deepening its unique fibre network in Europe. The company is undertaking this growth with a strong focus on sustainability and has been working hard through 2023 to deliver tangible progress on its long-term sustainability goals.
“Throughout euNetworks’ history, we have remained dedicated to our core values, and our commitment to sustainability has never been stronger,” said Paula Cogan, Chief Executive Officer of euNetworks. “We understand the impact our operations can have on the environment, and we are committed to reducing our carbon footprint and contributing to global efforts in combatting climate change and transitioning to a low-carbon economy.”
COP28 has a focus on four paradigm shifts – fast-tracking the energy transition and slashing emissions before 2030; transforming climate finance by delivering on old promises and setting the framework for a new deal on finance; putting nature, people, lives, and livelihoods at the heart of climate action; and mobilising for the most inclusive COP ever. euNetworks’ efforts align with those shifts.
“Our pledge to be net-zero carbon by 2040 is not just an aspiration but a driving force behind our actions,” said Cogan. “We have joined the Climate Pledge, demonstrating our unwavering commitment to combat climate change. Setting 1.5°C-aligned science-based targets across Scopes 1, 2, and 3 is a testament to euNetworks’ ambition to be leaders in environmental responsibility in the digital infrastructure ecosystem. We shifted to renewable energy sources across our business, and we’ve reached our target of 98.8% today. We obtained a Sustainability Linked Loan in 2021 that enabled us to embed our commitment to sustainability by including ESG-linked KPIs into our financial framework. We are dedicated to pioneering innovation in carbon measurement tools for service and project-based emissions, empowering our customers to measure and address Scope 3 emissions with precision, and helping suppliers to reduce their carbon footprint. Our award-winning carbon tools are actively used in our operations and by our customers today. We aim to deliver the lowest carbon footprint per bit of data transmitted, which we take seriously and drives our daily efforts.”
euNetworks’ sustainability strategy, outlined in the company’s latest Sustainability Report, encompasses long-term objectives, focusing on carbon neutrality, a diverse, equitable, and inclusive workforce, responsible supply chain management, customer-driven innovation, and biodiversity conservation:
- Net Zero: We have set our sights on achieving net-zero carbon emissions by 2040. This ambitious target involves increasing our use of renewable energy sources, implementing innovative technologies, and adopting efficient operational practices to minimise environmental impact.
- Diverse, Equitable, and Inclusive workforce: We champion an inclusive culture that values the richness of our employees' backgrounds and perspectives. We prioritise building a diverse, equitable and inclusive culture, and our goal is to achieve gender balance in our workforce, positioning us as a preferred employer within the telecoms industry.
- Responsible Supply Chain Management: We collaborate with our partners to establish responsible supply chain practices. This involves promoting transparency, ethical sourcing, and reducing our environmental footprint.
- Customer-Focused Innovation: We are committed to ongoing innovation, developing bandwidth infrastructure solutions prioritising energy efficiency, emissions reduction, and circular economy principles.
- Biodiversity Preservation: Our dedication extends to contributing to biodiversity conservation and ecosystem resilience. Our initiatives promote biodiversity awareness, protect natural habitats and support reforestation efforts.
“It’s clear that while euNetworks has made great progress towards its sustainability goals, we are still at the beginning of our journey,” said Cogan. “Collaboration among suppliers, customers, partners and the broader ecosystem will be essential to achieving substantial, long-term environmental change. In an industry fundamental to economies and society, euNetworks is committed to making significant sustainability strides of its own and supporting the bigger picture of businesses working together to solve the immense challenges of sustainability and climate change.”
To read euNetworks’ full Sustainability Report, go to https://eun.io/sustainability
About euNetworks
euNetworks is a critical bandwidth infrastructure company, owning and operating 17 fibre-based metropolitan networks connected with a high capacity intercity backbone covering 53 cities in 17 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 518 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231207410743/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
